MalaFA (Malaria Futures for Africa) is an opinion research study. It is the first systematic effort in many years to collect expert African views on malaria policy. It was commissioned by Novartis Social Business to capture the thoughts of 68 African malaria experts in 14 sub-Saharan African countries – ministers of health, members of parliament, senior civil servants working in health, heads of national malaria control programmes and representatives of academia and non-governmental organisations (NGOs) working on malaria.
The Compendium of WHO malaria guidance provides, for the first time, a complete list of all formal WHO policy recommendations on malaria in a single resource. The document also serves as a catalogue of all WHO publications on malaria prevention, diagnosis, treatment, surveillance and elimination.
Paris, 25 April 2019 – Today leaders from across the globe meet in Paris to renew commitments and announce new initiatives to accelerate the global movement to end malaria in our lifetime.
“For World Malaria Day, we’re joining countries and partners with a clear message: ‘Zero malaria starts with me,’” says the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, in his World Malaria Day message. “We’re calling on political leaders, the private sector and affected communities to take action to improve prevention, diagnosis and treatment of malaria. We all have a role to play.”
There is no doubt that bed nets, insecticides, medicines and diagnostics will deliver significant successes against malaria in the short-term. But as major international partners continue prioritizing the commodity-based approach, African governments should be building the necessary resilience in affected communities. Countries should ensure safe houses and physical environments so that exposure to mosquito bites is minimized, strengthen health systems to identify and treat new malaria cases, expand access to health education in schools and households, and improve household economies and food security so that competing priorities are addressed. This needs to be a long-term strategy, paid for by domestic funding, subsidies, tax rebates or other innovative financing mechanisms – for example a ten-dollar malaria levy paid by international travelers visiting endemic countries. This way, the affected countries can better avoid malaria deaths and sickness, or rebounds of transmission, which currently place such a strain on national health outcomes and development.
Country first of three in Africa to roll out landmark vaccine
WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine today in a landmark pilot programme. The country is the first of three in Africa in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age; Ghana and Kenya will introduce the vaccine in the coming weeks.
Nature News, 16 April 2019
A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions.
If you are working on malaria in East or Southern Africa you are invited to participate in the survey of the Embassy of Switzerland to Tanzania and Zambia.*